IFNA1 and carcinoma: Remarkably, IFN-priming does not significantly alter the total IFNα secretion over time, which is different from the sensitizing effects observed in a hepatocyte derived cellular carcinoma cell line upon priming with low dosages of IFN-I (Figure 3B) (36).